Show
Sort by
-
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)
-
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
-
- Journal Article
- A1
- open access
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
-
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma
-
A multilocus technique for risk evaluation of patients with neuroblastoma